Department of Medicine

September 17, 2020

New predictors of prostate cancer risk

An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk.

By Sarah E. Glass
Sourav Panja, PhD, underwent a complicated procedure at VUMC to treat his relatively rare form of pulmonary hypertension.
September 10, 2020

Technique helped treat patient’s rare pulmonary disorder

Sourav Panja, PhD, a postdoctoral scholar in the Department of Pediatrics at Vanderbilt University Medical Center, was working in his lab one evening last year when he began coughing up blood. Even breathing was becoming difficult.

By Matt Batcheldor
September 10, 2020

Award supports integration of genomic data, electronic health records

Eric Gamazon, PhD, assistant professor of Medicine, has been awarded a $1.5 million grant from the National Human Genome Research Institute, part of the National Institutes of Health (NIH), to develop novel computational tools that integrate functional genomic data and electronic health records.

By Leigh MacMillan
September 10, 2020

Roumie to direct Master of Public Health program

Christianne Roumie, MD, MPH, has been named director of the Vanderbilt University School of Medicine Master of Public Health program, a two-year interdisciplinary program accredited by the Council on Education for Public Health.

By Jake Lowary
September 7, 2020

Possible key to COVID-19 infectivity

New findings demonstrate how genetic variations in the receptor that binds SARS-CoV-2 impact virus recognition and infectivity and offer insights to COVID-19 susceptibility and treatment.

By Sarah E. Glass
August 20, 2020

Salt, immune cells and hypertension

Excess dietary salt activates immune cells to induce inflammation and hypertension, supporting current recommendations for low sodium consumption.

By Leigh MacMillan
August 20, 2020

A “torque” for tumor blood vessels

Vanderbilt scientists have discovered a new target for normalizing tumor blood vessels to improve cancer immunotherapies.
By Bill Snyder
August 20, 2020

‘Scavenger’ molecule may point to new atherosclerosis treatment

A small-molecule “scavenger” that reduces inflammation and formation of atherosclerotic plaque in blood vessels in mice potentially could lead to a new approach for treating atherosclerosis in humans, according to researchers at Vanderbilt University Medical Center.
By Bill Snyder
August 17, 2020

Rathmell named chair of Department of Medicine

After serving as interim chair since Jan. 1, Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine, has been named chair of the Department of Medicine in the Vanderbilt University School of Medicine and Physician-in-Chief for the Vanderbilt University Adult Hospital and Clinics.
By John Howser
August 13, 2020

Study suggests new threshold for diagnosing PAH

Doctors diagnosing pulmonary arterial hypertension (PAH) — elevated pulmonary pressure due to an issue in the small vessels of the lung — rely on a hemodynamic threshold set in the early 1970s to determine whether patients would be candidates for pulmonary vasodilator therapy.
By Matt Batcheldor
August 10, 2020

A step toward cancer prevention

A computational technique that combines the effect of multiple genomic variants has the potential to identify high-risk individuals for cancer prevention.
By Bill Snyder
August 6, 2020

Appendix cancer survival in young patients varies by race: study

The first study of appendiceal cancer patterns and survival by race/ethnicity among patients younger than 50 in the U.S. showed survival disparities.
By Leigh MacMillan
July 30, 2020

Device allows VHVI doctors to monitor heart patients remotely

In 2018, Ronnie Kreis began to develop severe heart failure. After being hospitalized multiple times that year near his home in Oliver Springs in East Tennessee, he was told that nothing else could be done.
By Matt Batcheldor
1 … 53 54 55 56 57 … 113